Case Report
Published on 04 Nov 2022
Acne caused by ziprasidone in a young patient with bipolar disorder: A case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.948977
- 3,765 views
- 3 citations
Type at least 3 characters
334 articles
Perspective
Published on 03 Nov 2022
Therapeutic setting as an essential component of psychedelic research methodology: Reporting recommendations emerging from clinical trials of 3,4-methylenedioxymethamphetamine for post-traumatic stress disorder
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.965641
- 6,693 views
- 15 citations
Original Research
Published on 03 Nov 2022
MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.939302
- 18,844 views
- 5 citations
Brief Research Report
Published on 26 Oct 2022
Preliminary evidence of links between ayahuasca use and the corpus callosum
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1002455
- 6,913 views
- 5 citations
Brief Research Report
Published on 26 Oct 2022
Effects of risperidone on psychotic symptoms and cognitive functions in 22q11.2 deletion syndrome: Results from a clinical trial
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.972420
- 2,227 views
- 1 citation
Original Research
Published on 21 Oct 2022
Synthetic cannabinoid JWH-073 alters both acute behavior and in vivo/vitro electrophysiological responses in mice
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.953909
- 4,436 views
- 6 citations
Original Research
Published on 19 Oct 2022
Selective D3 receptor antagonism modulates neural response during negative emotional processing in substance dependence
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.998844
- 4,339 views
- 4 citations
Editorial
Published on 18 Oct 2022
Editorial: Advances in therapeutic drug monitoring of psychiatric subjects: Analytical strategies and clinical approaches
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1056380
- 1,793 views
- 3 citations
Systematic Review
Published on 17 Oct 2022
Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.972141
- 8,616 views
- 13 citations
Mini Review
Published on 12 Oct 2022
Parvalbumin and parvalbumin chandelier interneurons in autism and other psychiatric disorders
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.913550
- 7,559 views
- 30 citations
Review
Published on 12 Oct 2022
A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.991753
- 18,819 views
- 15 citations
Perspective
Published on 11 Oct 2022
A methodological note on the CYP-guides randomized controlled trial for the treatment of major depression
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.888065
- 1,033 views
Original Research
Published on 10 Oct 2022
MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.932605
- 11,550 views
- 15 citations
Review
Published on 03 Oct 2022
3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.990405
- 8,868 views
- 6 citations
Perspective
Published on 29 Sep 2022
Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1017504
- 15,416 views
- 8 citations
Brief Research Report
Published on 28 Sep 2022
Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.992624
- 38,622 views
- 15 citations